Phase 1 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have an advanced solid tumor (a cancer that has grown or spread and forms a solid mass, rather than a blood cancer).
- Your cancer can be measured using standard imaging scans, according to a set of guidelines called RECIST v1.1.
- You are generally able to carry out daily activities with little or no limitation (confirm with trial site for exact definition).
- Your organs such as your liver, kidneys, and heart are functioning well enough to meet the trial's requirements (confirm with trial site for exact values).
Who may not be able to join:
- You are still experiencing significant side effects from a previous cancer treatment that have not yet mostly cleared up (hair loss and certain lab result changes may be exceptions — confirm with trial site).
- You have received certain cancer treatments — such as chemotherapy, targeted drugs, or biological therapies — too recently before starting this trial (within the last 14 to 28 days, depending on the type of treatment).
- You have brain metastases (cancer that has spread to the brain) that are getting worse or causing symptoms.
- You have a serious medical condition that is not well controlled, or you have an active infection that is not under control.
- You have a significant history of heart disease.
- You have a history of certain blood or bone marrow disorders called myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML).
- You have been diagnosed with another type of cancer within the past 3 years, with some exceptions such as certain treated skin cancers, early-stage breast cancer (DCIS), or low-risk prostate cancer (confirm with trial site for your specific situation).
- You are currently pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence and severity of adverse events and serious adverse events; Maximum Tolerated Dose (MTD); Recommended Phase 2 Dose (RP2D)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.